This Article supports SDG 3 by showing, through a modelling analysis, that community tenofovir, lamivudine, and dolutegravir (TLD) is likely to reduce HIV incidence and be cost-effective, thus leading to population health benefits.

This Article supports SDG 3 by showing that men who have sex with men (MSM) in Africa remain highly vulnerable to HIV acquisition and HIV-related mortality and morbidity, undermining the Global AIDS Strategy to end AIDS; realising the UNAIDS 95-95-95 targets and reducing disparities in HIV incidence requires urgent efforts to strengthen community-led prevention efforts.

In sub-Saharan Africa, many countries have policies and laws that discriminate against men who have sex with men. This paper explores the relationship between these laws and HIV in this key population.

This Article supports SDG 3 by highlighting findings from a population-level study of STI burden in Uganda, showing the need for global investment in innovative approaches that simultaneously test and treat HIV and STIs within existing health infrastructure, such as integrated HIV and STI service programmes within the President's Emergency Plan for AIDS Relief programme.

This Article supports SDG 3 by examining the potential impact of WHO's triple-intervention elimination strategy on cervical cancer incidence among women with HIV in South Africa. The authors note that cervical cancer elimination among women with HIV would necessitate more frequent screening (every 3 years).

This Article supports SDG 3 by showing that voluntary medical male circumcision remains a cost-effective, often cost-saving, prevention intervention in sub-Saharan Africa for at least the next 5 years.

SDG 3.3 is to end the AIDs epidemic, this study shows that of 793,902 people with HIV in Kenya included in the study >25% had low level viraemia, which is associate with a higher risk of virological failure. By defining virological supression as 50 copies/mL earleir interventions could be implmented, such as the use of dolutegravir, which could lead to epidemic control

This Article supports SDG 3 by seeking to understand barriers to uptake of HIV-preventive measures, by using a mathematical model simulating the HIV prevention cascade and HIV transmission. The study provides insights into the degree to which these barriers impede effectiveness of these measures and the degree to which they could be mitigated by interventions.

Population-based surveys are expensive and time consuming. By determining state-level seropositivity using national testing service data and a Bayesian linear model, a map of HIV prevalence was generated across the whole of Nigeria. By identifying the areas in which HIV is most prevalent interventions can be targeted. This less resource intense Bayseian method allows for national monitoring of HIV prevalence.

Previous studies have shown that people with HIV are at an increased risk of non-communicable diseases, this systematic review and meta-analysis collates data from 188 studies done in 21 sub-Saharan Africa countries and shows that people with HIV have an increased incidence of multiple NCDs, including hypertension, diabetes, and cervical cancer. Although more research is needed, this results highlight the need for improved treatment and prentative approaches to minimise the risk of people with HIV also developing non-comminicable diseases. Good health and wellbeing should not solely be focused on HIV managment; this study shows the growing risk of other diseases that have to be mitigated.